Synergistic action of increased oxygen tensions and PABA-folic acid antagonists on bacterial growth.
D062365:Aminobenzoates / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D003353:Corynebacterium diphtheriae / Q000187:drug effects; D003470:Culture Media; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D013293:Enterococcus faecalis / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007780:Lacticaseibacillus casei / Q000187:drug effects; D010100:Oxygen / Q000494:pharmacology*; D013411:Sulfadiazine / Q000494:pharmacology; D013416:Sulfamerazine / Q000494:pharmacology; D013418:Sulfamethazine / Q000494:pharmacology; D013444:Sulfisoxazole / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D062365:Aminobenzoates; D003470:Culture Media; D005493:Folic Acid Antagonists; D013411:Sulfadiazine; D013418:Sulfamethazine; D013444:Sulfisoxazole; D014295:Trimethoprim; D010100:Oxygen; D013416:Sulfamerazine